Rational Design and Development of an Acyclic Chelator H <sub>4</sub> pyox for Theranostic Radiometal Labeling under Mild Conditions
pyox for radiopharmaceutical development and provide a complementary choice in the design of metal-based radiopharmaceuticals and in the tuning of their pharmacokinetic properties─especially for targeting vectors with poor thermal stability.
Authors
- Jingjing Yao (ORCID: https://orcid.org/0000-0002-2608-0745)
- Jian Yan (ORCID: https://orcid.org/0000-0002-1267-2870)
- Chenhao Jia
- Zuoquan Zhao
- Xianzhong Zhang (ORCID: https://orcid.org/0000-0001-8591-8301)
- Yu Qiu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Translational Research in Oncology (FR)
Publication Details
- Journal
- Inorganic Chemistry
- Published
- 2026-04-27
- DOI
- https://doi.org/10.1021/acs.inorgchem.5c05511
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China